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ABSTRACT
Mammalian synthetic biology may provide novel
therapeutic strategies, help decipher new paths for
drug discovery and facilitate synthesis of valuable
molecules. Yet, our capacity to genetically program
cells is currently hampered by the lack of efficient
approaches to streamline the design, construction
and screening of synthetic gene networks. To ad-
dress this problem, here we present a framework
for modular and combinatorial assembly of func-
tional (multi)gene expression vectors and their ef-
ficient and specific targeted integration into a well-
defined chromosomal context in mammalian cells.
We demonstrate the potential of this framework by
assembling and integrating different functional mam-
malian regulatory networks including the largest
gene circuit built and chromosomally integrated to
date (6 transcription units, 27kb) encoding an in-
ducible memory device. Using a library of 18 differ-
ent circuits as a proof of concept, we also demon-
strate that our method enables one-pot/single-flask
chromosomal integration and screening of circuit li-
braries. This rapid and powerful prototyping platform
is well suited for comparative studies of genetic reg-
ulatory elements, genes and multi-gene circuits as
well as facile development of libraries of isogenic
engineered cell lines.
INTRODUCTION
Programming mammalian cells with large synthetic gene
networks is expected to play a central role in helping eluci-
date complex regulatory cellular mechanisms (1–4), imple-
menting new useful biological functions (5–7) and acceler-
ating the design of novel tailor-made therapeutic treatments
(8–14). However, our limited ability to precisely engineer
and predict the behavior of these genetic programs in mam-
malian cells remains a major challenge (8). Toward system-
atic and rational engineering of mammalian cells, new tools
andmethods are required that enable rapid prototyping and
validation of genetic circuits in a standardized manner.
Stable chromosomal integration of genetic payloads can
help achieve long-term expression of transgenes. Given the
pleiotropic effect of the integration locus on transgene ex-
pression, it is critical to be able to study and compare the
function of the integrated genetic components, genes or
networks in the same genomic context (15). Gene transfer
methods, such as retroviruses, lentiviruses and transposons,
are therefore not well suited because they result in random
integration and the copy number of the integrated payload
is not controlled well.Moreover, such techniques often limit
the size of the payload to a few kilobases and do not tolerate
the presence of repetitive sequences, which is often essential
for genetic circuits comprising multiple transcription units.
Several approaches have been developed that focus on tar-
geted integration of foreign DNA into a transcriptionally
active locus. Recent engineering of meganucleases, zinc fin-
ger nucleases (ZFN), TALENs and CRISP/Cas9 systems
enable efficient integration of small DNA fragments at the
locus of choice in mammalian chromosomes (16–19). How-
ever, such strategies involve double-strand break repair by
homologous recombination or non-homologous end join-
ing, which can lead to frequent head-to-tail concatemer in-
tegrations (15), partial integration of the DNA fragments
(Supplementary Figure S1) or sequence alteration close to
the target site (20) and are therefore not well suited for single
copy integration of large multi-gene payloads. Moreover,
time-consuming clonal expansion and insert verification are
almost always required due to the high frequency of off-
target and multi-copy integrations (21). Alternatively, pre-
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cise integration of intact constructs can be achieved using
site-specific recombination technologies (22–25), although
the use of these techniques for integration of genetic net-
works in mammalian cells has not been demonstrated yet.
To address these challenges, we developed a comprehen-
sive framework for simple and efficient generation of en-
gineered cell lines that stably express multi-component ge-
netic networks in the same chromosomal context (Figure 1).
Our strategy consists of three main components: (i) engi-
neering of monoclonal chassis (landing pad) cell lines, (ii)
fast and modular assembly of large synthetic circuits and
(iii) targeted integration of the assembled circuits into the
landing pad of the chassis cell lines with an efficient Bxb1
site-specific recombinase. Once the chassis cell line is gen-
erated, our method allows us to proceed from genetic parts
(genes, promoters of choice) to functional assays of assem-
bled and integrated circuits in mammalian cells in as little
as 20 days. We demonstrate that the unique combination
of very high integration efficiency, specificity and integrity
(intact, functional payload) provided with our method en-
ables rapid generation of nearly isogenic polyclonal cell
populations characterized by highly homogenous and cor-
related transgene expression. We show scalability of the ap-
proach by construction, targeted chromosomal integration
and functional validation of the largest mammalian genetic
circuit that has been integrated to date (42 parts, 6 tran-
scription units, 27 kb). Finally, we performed a one-flask
integration of a multi-gene payload library to demonstrate
the suitability of our method for high-throughput screen-
ing of circuit libraries. As a whole, our method paves the
way for robust and fast prototyping of synthetic genetic net-
works and provides a modular platform to streamline the
generation of engineered isogenic stable cell lines, useful for
a broad research community.
MATERIALS AND METHODS
Golden gate reactions
For all Golden Gate assembly reactions we used: 0.4 l of
TypeIIS enzyme (either BsaI from NEB, or BpiI from Fer-
mentas), 0.2 l of T4 Ligase HC + 1 l of T4 Ligase HC
buffer (Promega), 1l of 10x bovine serum albumin (NEB),
40 fmol for all vectors used in the reaction, ddH20 up to a
final total volume of 10 l. The thermocycler program used
for all assemblies included: 1 step of 15 min at 37◦C; then 50
cycles of [2 min at 37◦C followed by 5 min at 16◦C]; 1 step
of 15 min at 37◦C, 1 step of 5 min at 50◦C and 1 final step
of 5 min at 80◦C.
Bacterial cell cultures
Liquid cultures of Escherichia coli MG1655 were grown
in LB Medium (Difco) at 37◦C for plasmids up to 20 kb,
and at 30◦C for larger plasmids. When appropriate, antibi-
otics were added as follows: spectinomycin (100 g/ml),
ampicillin (100 g/ml) and kanamycin (25 g/ml). For
blue/white screening, we used X-gal at a final concentration
of 40 g/ml.
Cell cultures, transfections and nucleofections
HEK293FT and HEK293 cell lines were purchased from
Invitrogen. HeLa (CCL.2), CHO, COS, hESC cell lines
were obtained from ATCC. HEK293FT, HEK293, HeLa
and CHO cells were maintained in Dulbecco’s mod-
ified Eagle’s medium (DMEM, Cellgro) supplemented
with 10% Fetal Bovine Serum (FBS, PAA), 0.045 g/ml
penicillin/streptomycin and non-essential amino acids (Hy-
Clone) at 37oC, 100% humidity and 5% CO2. mESC were
grown inDMEM supplemented with 15%Fetal Calf Serum
(FCS, 10 ng/ml LIF/ESGRO (Millipore), 0.1 mM MEM
non-essential amino acids, 100 U/ml penicillin, 100 g/ml
streptomycin and 100 M Mercaptoethanol. COS cells
were grown in DMEM supplemented with 10% FCS and
0.045 g/ml penicillin/streptomycin. hESC (CHB8, gift of
George Daley, Harvard Medical School) were grown on
Matrigel-coated plates in mTeSR-1 (Stem Cell Technolo-
gies, Vancouver, Canada). HEK293FT and HEK293 trans-
fections were carried out in 24-well plates using Attractene
reagent (Qiagen), 200 000 cells and 200–300 ng total DNA
per well. Media were changed 24 h after transfection.
mESC were transfected using Metafectene Pro (Biontex,
Germany). Transfection was performed in 6-well plates us-
ing 800 000 cells and 2 g of DNA. COS cells were trans-
fected using Metafectene Pro. Transfection was performed
in 6-well plates using 600 000 cells and 2 g of DNA. For
Hela, CHO, hESC we used the 4D Nucleofector (Lonza,
Switzerland) to electroporate the vectors. For hESCwe used
600 000 cells, 800 ng total of DNA and the nucleofection
program CA-137 (Buffer P2). For CHO we used 600 000
cells, 600 ng total of DNA and the nucleofection program
DT-133 (Buffer SF). For HeLa we used 800 000 cells, 800
ng total of DNA and the nucleofection program CN-114
(Buffer SE).
Landing pad integration using ZFN
To create the pLanding Pad vector, an 800 bp sequence
homologous to the AAVS1 sequence on the left of the
ZFN cut site, was cloned into the p TU1 position vector.
Similarly, an 800 bp sequence homologous to the AAVS1
sequence on the right of the ZFN cut site, was cloned
into the p TU3 position vector. The following transcrip-
tion unit was assembled into the p TU2 position vector
with a golden gate reaction: double cHS4 core insulator
from a p Insulator, CAG promoter from a p Promoter,
attP BxB1 from a p 5′UTR, EYFP-2A-Hygromycin from
a p Gene, inert 3′ UTR from a p 3′ UTR and rb glob
polyAdenylation signal + double cHS4 core insulator from
a p polyA. The three verified position vectors were then as-
sembled altogether into the Shuttle Vector, deleting the crt
red operon cassette. To create the ZFN expressing vector,
pLV CAG CN-2A-CN, the cDNA encoding the two ZFD
for the AAVS1 locus, separated by a 2A tag was synthesized
(GeneArt, Regensburg, Germany) and polymerase chain
reaction (PCR)-amplified with Gateway attB1/attB2 tags.
Upon gel extraction, the PCR product was recombined into
a pENTR L1 L2 vector using BP clonase (Life Technolo-
gies, Carlsbad, CA, USA), yielding the pENTR L1 CN-
2A-CN L2 vector. In a next step, pENTR L1 CN-2A-
CN L2 and pENTR L4 CAG R1 were recombined into
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Figure 1. Overview of the circuit construction and integration framework. (A) First phase: chassis cell-line generation. A landing pad is integrated into
the locus of a WT cell line of choice using a zinc-finger nuclease, TALEN or CRISPR-Cas system. Integration events are then selected with hygromycin
and resistant clones are expanded. Finally, Southern blots and PCRs are performed on different clones to verify the insertion locus and integrity of the
landing pad. (B) Multi-gene circuit integration details. Co-transfection of the integration vector and the recombinase expression plasmid results in site-
specific recombination between the BxB1 attB site (from the integration vector) and the attP site (pre-integrated in the mammalian chromosome within the
landing pad). As a result, expression of the promoterless selection marker from the integration plasmid is triggered since it is inserted after the constitutive
promoter of the landing pad. (C) Second phase: Multi-gene circuit assembly and integration in the landing pad. The monoclonal chassis cell line can be
used to integrate multi-gene circuits constructed with the mMoclo assembly method, which requires only two cloning steps from sequenced-verified basic
genetic parts to complete multi-gene circuits. Depending on the application, either a single circuit or a library of circuits can be co-transfected with BxB1
recombinase expression plasmid. Cell populations are ready to be screened in less than 2 weeks after transfection.
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pLV R4R2 GTW using LR clonase II plus (Life Technolo-
gies), resulting in pLV CAG CN-2A-CN. To integrate the
landing pad into the AAVS1 locus, we co-transfected cells
with equimolar amount of the ZFN vector and the pLand-
ing Pad vector. Seventy-two hours post-transfection cell
culture medium was supplemented with 200 g/ml Hy-
gromycin B (Invivogen) and the selection was maintained
over a period of 2 weeks. Clonal cell lines were generated by
serial dilutions of the surviving population.
Southern blots
Genomic DNA was extracted with the Quick-gDNA
MidiPrep kit (ZYMO RESEARCH). Note that 4 g of
gDNA was digested over night with the EcoNI and XbaI
(Landing Pad integration test) or with AseI (circuit inte-
gration test), separated on 0.8% agarose gel, transferred
to a nylon membrane and probed with the indicated 32P-
radiolabeled probe (Supplementary Text 1). Biomax MS
film (KODAK) were stored 2 days in an exposition cassette
with the membrane and revealed with a darkroom X-Ray
processor (Velopex MD2000).
BxB1-mediated integration of circuits
To integrate circuits into the landing pad of HEK293FT
chassis cell line, we co-transfected 150 ng of the appropri-
ate multi-gene integration vector with 150 ng of BxB1 in-
tegrase expression vector using attractene (Qiagen) in 24-
well format. Seventy-two hours post-transfection cells were
transferred to 6-well plates and culture medium supple-
mented with 1 g/ml puromycin (InvivoGen). Unless oth-
erwise noted, selectionwasmaintained for 5 days. Cells were
typically assayed 14 days post-transfection. For induction
of the TRE promoter, 2 ug/ml doxycycline was used.
Integration efficiency test
Cells were collected by trypsinisation from 24-well plates 24,
48 and 72 h after transfection. Cells were then pelleted (1600
g; 3 min) and resuspended in 300 l of Phosphate Buffered
Saline (PBS).
Lentiviral particle production and infection
We used Gateway (26) cloning to construct the integra-
tion vectors. Our lentiviral Gateway destination vectors
contain pFUGW (27) (Addgene plasmid 14883) backbone
and Gateway cassette (comprising chloramphenicol resis-
tance and ccdB genes flanked by attR4 and attR2 recom-
bination sites) followed by blasticidin or puromycin re-
sistance markers expressed constitutively. LR reaction of
the destination vectors with entry vectors carrying human
elongation factor 1 alpha (hEF1a) promoter and either
mKate2 or EBFP2 fluorescent proteins was used to cre-
ate the following expression vectors: pLV-hEF1a-mKate2-
P2A-Puromycin and pLV-hEF1a-EBFP2- P2A-Blasticidin.
For production of lentiviral particles ∼2 × 106 HEK293FT
cells (Invitrogen) in 3 ml of DMEM complete media were
plated into gelatin-coated 60 mm dishes (Corning Incorpo-
rated). Three hours later the ∼80% confluent cells were co-
transfected with 0.5 g of the pLV-hEF1a-mKate2-P2A-
Puromycin expression vector, 1.1 g packaging plasmid
pCMV-dR8.2 (Addgene plasmid 8455) and 0.55 g enve-
lope plasmid pCMV-VSV-G (Addgene plasmid 8454) (28)
using Attractene reagent (Qiagen) and following manufac-
turer’s protocol. Media containing viral particles produced
from transfected HEK293FT cells were harvested ∼48 h
post-transfection and filtered through a 0.45 m syringe
filter. Note that 1.5 ml of the filtrate was added to ∼20%
confluent HEK293FT cells in 12-well plate seeded immedi-
ately before infection. After 48 h, media were changed and
supplemented with 1 g/ml puromycin (InvivoGen). Cells
were maintained under selection for 5 days. After selection
and expansion, cells were infected again with lentiviral par-
ticles produced using pLV-hEF1a-EBFP2-P2A-Blasticidin
expression vector, following the same protocol. Blasticidin
selection (10 g/ml) (InvivoGen) was applied for 7 days.
Cells were subsequently analyzed by flow cytometry.
Flow cytometry and data analysis
Cells were analyzed with LSRFortessa flow cytometer,
equippedwith 405, 488 and 561 nm lasers (BDBiosciences).
We collected 30 000–50 000 events, using a forward scatter
threshold of 5000. Fluorescence data were acquiredwith the
following cytometer settings: 488 nm laser and 530/30 nm
bandpass filter for EYFP, 561-nm laser and 610/20 nm fil-
ter for mKate2, 405 laser and 525/50 filter for AmCyan and
405 nm laser, 450/50 filter for Pacific Blue. Data analysis
was performed with FACSDiva software (BD Biosciences)
andFlowJo (http://www.flowjo.com/). For histogramanaly-
sis, flow cytometry data in .FCS format were exported into
text format using FCS Extract 1.02 software (E.F. Glynn,
Stowers Institute for Medical Research) and analyzed in
Microsoft Excel. We used bi-exponential scales for visualiz-
ing fluorescence-activated cell sorting (FACS) data. For cell
sorting, cells were collected directly into an 8-well micro-
slide (Ibidi) by a FACSAria cell sorter.
Microscope measurements and image processing
Fluorescence microscopy images of live cells were taken in
glass-bottom dishes or 12-well plates using Zeiss Axiovert
200 microscope and Plan-Neofluar 10x/0.30 Ph1 objective.
The imaging settings for the fluorophores were S430/25x
(excitation) and S470/30m (emission) filters for AmCyan,
and S565/25x (excitation) and S650/70m (emission) for
mKate2.Data collection and processingwere performed us-
ing AxioVision software (Zeiss). For the circuit library ex-
periment, we evaluated 500 cells from three different fields
of views for each replicate transfection (total of 4500 cells
examined). We manually marked all cells with a specific
tag corresponding to its observed phenotype and used an
Adobe Illustrator automated script to sum the number of
cell instances for each cell type and each field of view.
RESULTS
Chassis cell lines generation
To generate the chassis cell lines (Figure 1a), we created a
landing pad vector for integration into the chromosomal
locus of choice using engineered ZFN. The landing pad
contains a constitutive promoter driving co-expression of
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a fluorescent protein (EYFP) and a selection marker (Hy-
gromycin) (Figure 1b). Between the promoter and the cod-
ing sequence we inserted an attP BxB1 phage attachment
site (29) to enable site-specific recombination in the landing
pad. Co-transfection in the chassis cell line of a vector car-
rying the corresponding attB BxB1 attachment site with a
vector expressing the BxB1 recombinase results in attB/attP
site-specific recombination and insertion of the complete
vector in the landing pad. To limit interference with sur-
rounding host genes, we placed insulator sequences on both
sides of the transcription unit (30). We integrated the land-
ing pad into the AAVS1 locus (21,31) of one simian (Cos)
and four human model cell lines (HEK293FT, HEK293,
Hela and human Embryonic Stem Cells). This locus was
chosen because it promotes sustained expression of trans-
genes (32). Similarly, we targeted the Rosa26 locus of a
mouse Embryonic Stem Cells line and a Chinese Hamster
Ovary cell line, as it also supports robust gene expression
(19). In this study we focus primarily on characterization
and testing of the HEK293FT chassis cell line. After se-
lection and expansion of clonal populations resistant to
hygromycin, we isolated a HEK293FT-Landing Pad (LP)
monoclonal cell line that showed correct mono-allelic in-
tegration of the landing pad, as confirmed with Southern
blot and PCRs (Supplementary Figures S2 and S3). EYFP
expression in the confirmed chassis cell lines was sustained
at high levels for over 40 passages (maximal duration of
culture) without further antibiotic selection. While time-
consuming (5–6 weeks), monoclonal selection, expansion
and verification of the landing pad cell line is required only
once with our method, as the cell line can be stored and
reused for all subsequent BxB1-mediated integrations (Fig-
ure 1c).
Mammalian modular cloning (mMoClo)
To create a framework for modular multi-gene circuits con-
struction and integration into the landing pad of our chas-
sis cell lines, we extended the previously developedModular
Cloning strategy (33) (Figure 2 and Supplementary Figure
S4). This highly efficient assembly method (95–100% cor-
rectly assembled constructs) (34) relies on flanking the dif-
ferent circuit basic elements with Type IIs restriction en-
zyme sites that create unique 4 bp overhangs in order to
obtain predetermined positioning of the parts within the
overall circuit. The mMoclo we introduce here includes
6 parts positioning vectors, 9 transcription unit position-
ing vectors, 9 linker vectors and 1 destination vector (Fig-
ure 2a). The parts positioning vectors are used to create a
sequence-verified library of all the basic components nec-
essary to construct an insulated mammalian transcription
unit: insulators (in pInsulator), promoters (in pPromoter),
5′ UTR sequences (in p5′ UTR), gene coding sequences (in
pGene), 3′ UTR sequences (in p3′ UTR) and polyA sig-
nals (in ppolyA). These parts are used to assemble either
(i) functional transcription units into the ‘transcription unit
positioning vectors’ (Figure 2b) or (ii) a promoter trap cas-
sette carrying attB BxB1 recombination site followed by a
promoterless selectionmarker of choice into the destination
vector, to create an integration vector (Figure 2c). A com-
plex multi-unit circuit can then be assembled into this in-
tegration vector by combining transcription units with the
corresponding linker vector chosen according to the num-
ber of transcription units of the circuit (Figure 2d). The vec-
tor backbone used for the assembly of large circuits carries
a pBR322 origin of replication and can be used to amplify
circuits up to 31 kb.While transformed bacteria were grown
at 37◦C for circuits up to 20 kb, we reduced the growth tem-
perature to 30◦C for circuits above this size in order to min-
imize deletions in the circuits.
Site-specific integration into the landing pad
To assess integration efficiency, we created an integration
vector that contains mKate2 fluorescent reporter fused
to a promoterless resistance marker such that integration
events can be monitored easily with flow cytometry (Fig-
ure 3a). Constitutively expressed Cerulean fluorescent re-
porter gene was also included in the integration plasmid to
determine the transfection efficiency. We co-transfected our
HEK293FT-LP chassis cell line with the integration plas-
mid and a plasmid expressing BxB1 recombinase (wild-type
or codon optimized versions), and monitored expression of
the fluorescent reporters. Three days after transfection, 10%
of the transfected cells expressed mKate2 (8% of the entire
population) (Figure 3b). BxB1 codon optimization yielded
a 3-fold improvement in integration efficiency over wild-
type BxB1 coding sequence. No integration events were ob-
served when the integration plasmid was transfected with-
out the BxB1 expressing plasmid. Addition of a nuclear
localization signal (NLS) to the recombinase did not in-
crease the integration efficiency (Supplementary Figure S5).
We also tested different ratios of the integration plasmid
versus the BxB1 expression plasmid to determine whether
vector titration would influence the integration efficiency
(Supplementary Figure S6) and found that a 1:1 ratio re-
sulted in the highest integration efficiency. After confirm-
ing the proper function of the platform in all our chassis
cell lines (Supplementary Figure S7), we assessed the in-
tegration efficiency in two of them (CHO and HeLa). We
found that a similar integration efficiency was obtained in
these cell lines (Supplementary Figure S8). To assess the in-
tegration specificity of the promoter-trap strategy, wemoni-
tored expression of mKate2 and EYFP among the resistant
cells after puromycin selection. More than 99% of the re-
sistant cells carried a single targeted integration of the full
vector into the landing pad (mKate2 positive, EYFP neg-
ative) while less than 1% of resistant cells expressed both
mKate2 andEYFP (0.23% forHEK293FT, 0.43% forHeLa
and 0.86% for CHO, Supplementary Figure S9), account-
ing for rare integration events into cryptic acceptor sites
placed after an endogenous constitutive promoter. To vali-
date these flow cytometry statistics and further demonstrate
the platform’s ability to generate nearly isogenic engineered
cell populations, we randomly isolated and expanded 42
resistant clones derived from the HEK293FT-LP cell line
and analyzed their genomicDNAwith Southern blots. Cor-
rect integration in the landing pad was confirmed for all 42
clones (Supplementary Figure S10). We also sequenced the
flanking sequences of the insert for these 42 isolated clones
and confirmed that the integration process did not trigger
any small insertions or deletions close to the recombina-
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Figure 2. Overview of mammalian circuit assembly (mMoClo). (A) mMoClo is based on a library of empty backbones used to assemble parts (Parts
Positioning Vectors), transcription units (TranscriptionUnit Positioning Vectors) and complexmulti-unit circuits (Destination Vector) to be integrated into
the landing pad. The Parts Library is made of sequence-verified basic genetic parts (Insulators, Promoters, 5′ UTR, Genes, 3′UTR and polyA sequences).
(B) One-step creation of an integration vector carrying BxB1 attB site and promoterless selection marker. (C) One-step assembly of different functional
transcription units in specific position vectors. (D) One-step assembly of a multi-unit genetic circuit by combining the desired transcription units, the
corresponding linker vector and the previously built integration vector carrying the promoter-trap cassette. Details of the overhangs used in the assembly
process are provided in Supplementary Figure S4.
tion site (Supplementary Figure S11). To assess the ability
to transfer the platform to other cell lines, we co-transfected
both the integration plasmid and the BxB1 expressing plas-
mid in all our chassis cell lines.
Expression homogeneity of multi-genic integrated constructs
in a polyclonal cell population
The high integration efficiency and specificity of the
recombinase-based method, combined with its ability to
preserve intact payload, should result in homogenous ex-
pression of transgenes from a multi-genic construct even
in polyclonal cell populations. To validate this hypothesis,
we created a more complex integration vector containing
a promoterless puromycin resistance marker followed by
three transcription units constitutively expressing mKate2,
EBFP2 and Blasticidin each using a separate promoter. To
monitor fluorescence levels, we co-transfected this circuit
together with the BxB1 expression vector, initiated a 5-day
puromycin selection 3 days after the transfection and grew
the surviving cells for 6 additional days without any selec-
tion before FACS analysis. As desired, we obtained highly
homogenous expression of the two fluorescent proteins. We
observed that the variability of transgene expression in the
polyclonal population after integrationmeasured by the co-
efficient of variation (CV) (mKate2: = 49.4%; EBFP: CV
= 43.1%) is similar to that of the monoclonal chassis cell
line population (EYFP: CV = 47.2%) (Figure 3c and d).
We also observed that expression of transgenes placed on
the same payload is highly correlated (coefficient of corre-
lation r = 0.81, Figure 3d). Similar results were confirmed
with other chassis cell lines (Supplementary Figure S12).
In comparison, polyclonal populations generated by widely
used viral-based integration strategies exhibited a stronger
signal due to a high multiplicity of infection but larger vari-
ances and amarkedly lower correlation in transgene expres-
sion (mKate2: CV = 94.2%; EBFP: CV = 88.6%; r = 0.21)
 at M








13446 Nucleic Acids Research, 2014, Vol. 42, No. 21
Figure 3. Integration efficiency and homogeneity of payload expression. (A) Fluorescence microscopy images of HEK293FT–LP chassis cell line 3 days
after co-transfection of the integration vector and the recombinase expression plasmid. Site-specific integration events can be monitored by expression of
mKate2 and concomitant decrease in EYFP levels (integrated circuits shown on top). Cells that undergo the yellow to red switch, indicating successful
integration, are denoted with arrows. (B) Integration efficiency assayed by flow cytometry defined as the percentage of cells expressing mKate2 among
the population of transfected cells, without any selection. Error bars represent standard deviation from three biological replicates. (C) Homogeneity of
transgene (EYFP) expression in HEK293FT-LP cell line. (D) Schematic representation of integrated multi-gene circuits and representative FACS analysis
histograms of cells selected with puromycin after BxB1-mediated integration or (E) lentivirus-mediated random integration. Targeted integration results
in high homogeneity of transgene expression as compared to lentiviral integrations. The representative fluorescence 2D density plots show high correlation
between expression of the fluorescent reporters after single-copy integration in the landing pad as compared to lentiviral integrations.
(Figure 3e). To generate these polyclonal populations, we
had to infect the cells with two separate lentiviruses (given
the limited packaging capabilities of the lentivirus parti-
cles), one encoding the Hef1a EBFP-P2A-Blasticidin tran-
scription unit and the other encoding the Hef1a mKate2-
P2A-Puromycin. To select for integrations, we first applied
puromycin for 5 days followed by blasticidin for 7 days be-
fore FACS analysis.
Integration of a 7-gene payload encoding an inducible mem-
ory device
To test the scalability of our method with respect to pay-
load size and number of transgenes, we constructed and in-
tegrated a large gene circuit (42 basic parts, 6 transcription
units, 27 kb, Supplementary Figure S13a) encoding an in-
ducible memory device (Figure 4). At the initial state, prior
to doxycycline induction, the circuit constitutively expresses
the Cerulean fluorescent protein. Upon induction, expres-
sion of both EYFP and B3 site-specific recombinase (or-
thogonal to BxB1) are triggered, which results in precise
genomic rearrangement within the circuit. Specifically, B3
recombinase recognizes the B3 recombination sites flank-
ing the Cerulean coding sequence, which is then excised.
The promoterless downstream mKate2 coding sequence is
thus placed in frame with the constitutive promoter previ-
ously activating the Cerulean gene expression. The circuit
is therefore locked into a final state in which the output
has been switched from constitutive Cerulean expression to
constitutive mkate2 expression. Following transfection, in-
tegration and selection with puromycin for 5 days, wemoni-
tored expression levels of the different fluorescent reporters
before, during and after induction of genomic rearrange-
ment with doxycycline (Figure 4b). At the end of the selec-
tion, after circuit transfection but before doxycycline induc-
tion, about 40% of the selected cells had already switched
from Cerulean to mKate2 expression (Supplementary Fig-
ure S13b). As this ratio was stable over time and essen-
tially no cells had an intermediate level of either Cerulean
or mKate2, we hypothesized the B3-mediated switch had
occurred right after transfection since leaky TRE promoter
expression from the transfected circuits in the presence of
high levels of constitutively expressed rtTA3 from the same
plasmids was sufficient to trigger expression of B3 integrase
at low levels. This would then result in moderate excision
of the Cerulean expression cassette in the pool of plasmids,
whether or not they had been already integrated in the land-
ing pad.
To gain improved understanding, we performed a doxy-
cycline induction experiment (Figure 4b) with cells har-
boring a non-rearranged payload only (mKate2-negative
sorted cells).Wemonitored expression levels of the different
fluorescent reporters before, during and after induction of
genomic rearrangement (Figure 4b). Before induction with
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Figure 4. Transcriptional regulation and genomic rearrangement for a 7-gene circuit integrated into the landing pad of HEK293FT chassis cell line. (A)
Schematic representation of the integrated circuit. In its initial state, the circuit expresses puromycin resistance gene, Cerulean, rtTA3 and Blasticidin
resistance gene. After dox induction, rtTA3 activates TREt promoter and triggers expression of EYFP and B3 recombinase (Step 1). This leads to the
intermediate state, during which B3 integrase mediates excision of the Cerulean cassette by recombination of the two attB3 sites. Subsequently, mKate2
gene is expressed. When dox is removed, EYFP is no longer expressed. In the final state, mKate2 is the only reporter that is expressed. (B) Fluorescent
microscopy images and flow cytometry results confirmed the correct behavior of the circuit and show homogeneity of transgene expression in the polyclonal
cell population. (Intermediate state: 3 days after dox induction; Final state: 7 days after dox removal.)
doxycycline, the circuit remained in its stable initial state
with a highly homogenous expression of Cerulean in the
population. Efficient transition between the device’s states
could be successfully monitored 3 days after induction of
the circuit with doxycycline at the same time through the
strong activation of EYFP and mkate2 expression, and the
slow reduction in Cerulean levels. The B3-induced genetic
rearrangement therefore locks the circuit into a new state
with constitutive expression of mKate2. After withdrawal
of doxycycline,mKate2 is still constitutively expressedwhile
EYFP expression diminishes, as the induced B3-mediated
genetic rearrangement is irreversible. Flow cytometry anal-
ysis of the polyclonal population showed homogenous ex-
pression in the population for all reporters at the differ-
ent time points (Figure 4b). These results suggest that our
framework preserves the genetic integrity of such large pay-
loads and provides not only homogenous expression of all
transgenes without monoclonal expansion but also reliable
dynamic behavior.
Integration of a library of 18 circuits
Finally we examined the suitability of our platform for
high-throughput screening of multi-genic payload libraries.
As a proof of concept, we performed three replicate co-
transfections of the HEK293FT-LP chassis cell line with
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an equimolar mix of 18 different plasmids (each contain-
ing one distinct circuit) together with the BxB1 expression
plasmid (Figure 5). Each circuit encoded a fluorescent re-
porter fused to a NLS and a different fluorescent reporter
with variable cellular localization tags such that each circuit
generates a distinct fluorescence phenotype (Figure 5b and
Supplementary Figure S14). Fourteen days after transfec-
tion, we evaluated the phenotype of 1500 cells from each of
the three polyclonal populations (total of 4500 cells exam-
ined) and observed that all 18 phenotypes were represented
well (Figure 5e).
DISCUSSION
In this study, we introduce and validate a comprehensive
framework for rapid prototyping of mammalian multi-gene
synthetic networks. The framework combines a modular
and rapid DNA assembly method to create the circuits to-
gether with a platform for stable integration of large syn-
thetic gene networks in a predefined location in a mam-
malian chromosome.We demonstrate that our method pro-
vides an efficient and reliable strategy for correct and sus-
tained execution of complex genetic programs in mam-
malian cells.
Engineering of cellular behavior remains a challenge and
is still strongly dependent on the ability to screenmany vari-
ants of a designed genetic program in a manner that allows
direct comparison of the results. To accelerate the develop-
ment of such libraries, we developed mMoClo, an exten-
sion of the MoClo assembly method, specifically tailored
for construction of mammalian genetic circuits. mMoClo
enables modular and combinatorial assembly of sequence-
verified basic genetic parts into mammalian transcription
units and then multi-unit gene circuits in only two cloning
steps. Our extension confers an important advantage com-
pared to other assembly methods previously developed for
mammalian systems (35–37). In particular, the design of
the library reflects the structure of a functional mammalian
transcription unit and allows combinatorial generation of a
vast diversity of transcription units and circuits from basic
sequence-verified genetic parts, from short 3′ and 5′ UTR
sequences to large insulator sequences. We believe such a
method could provide a new and broadly used standard for
assembly of mammalian transcription units and complex
circuits. To disseminate our platform, we deposited in Ad-
dgene a library of more than 120 parts and 20 assembly vec-
tors (2 different insulators, 8 promoters, 20 5′ UTRs, 90 cod-
ing sequences, 8 3′ UTRs and 6 polyadenylation signals).
We assembled circuits up to 31 kb, although larger plasmids
exhibited deletions or rearrangements during the bacterial
cloning phase, likely due to the limited stability conferred by
the pBR322 origin of replication for large plasmids. As an
alternative more suitable for larger circuits, one could po-
tentially replace the origin of replication of our destination
vector with a BAC origin of replication, often used for the
amplification of large circular DNA fragments (38).
To study and compare the different circuits we assembled
with the mMoClo method, we created a stable integration
platform, the landing pad, which can be inserted in specific
loci of different cell types using engineered nucleases. While
we used ZFN in this study, other efficient systems, such as
CRISPR/Cas or TALEN, could also be chosen for chromo-
somal insertion of the landing pad. Even though variation
in DNA integration efficiency will differ according to both
the nuclease used and the cell line, it is important to note
that only a very limited number of candidate clones that
survive selection are necessary in order to isolate and val-
idate one functional chassis cell line. In this case, any of the
available nucleases are therefore good candidates to gener-
ate chassis cell lines. The landing pad platform we created
carries a BxB1 recombination site located downstream of
a constitutive promoter and therefore acts as a synthetic
promoter trap to allow for quick selection of targeted in-
tegration events. Such a strategy significantly reduces the
survival likelihood of cells with circuit integration in cryp-
tic pseudo-att sites. Once a monoclonal landing pad chassis
cell line is created, it can then be repeatedly used for single
copy targeted integration of synthetic circuits mediated by
our efficient codon-optimized BxB1 site-specific recombi-
nase. While this is not the first study to use recombination
sites for the creation of engineered cell lines, we demonstrate
here a comprehensive platform based on the targeted inser-
tion of a tailor-made landing pad in a wide range of cell
lines, which can then be used to efficiently generate nearly
isogenic cell populations carrying single and targeted copies
of modularly assembled complex genetic circuits. This com-
bination of mMoClo and our landing pad platform there-
fore becomes a convenient framework to significantly re-
duce the time from transfection of an integration vector to
assay (from 2 months to 2 weeks) and to avoid the mono-
clonal expansion typically required when engineering cells
with (multi)gene circuits.
We validated the approach by assembling the largest
known functional mammalian synthetic circuit to date, in-
tegrating it into the landing pad of a HEK293FT mono-
clonal chassis cell line, and assessing its behavior within the
polyclonal population of selected cells 2 weeks after trans-
fection. Due to the unique combination of high integration
efficiency, little to no off-target effect and robust preserva-
tion of payload integrity, we obtained sustained and homo-
geneous expression of the genetic program. The desired ge-
nomic rearrangement was triggered with the same dynam-
ics in the selected polyclonal cell population after induction
of specific transgenes with doxycycline. For various applica-
tions, it would be important to integrate vectors without any
bacterial sequences, as the presence of CpG nucleotides in
these sequences has been shown to potentially lead to post-
integrative silencing of the transgene (39). One possibility is
to use the Minicircle (40) strategy to excise such sequences
before transfection of the vectors, or use efficient excision-
ases, such as Cre or Dre (41), after integration of the circuit.
To validate the suitability of our framework for the com-
binatorial assembly and screening of large circuit libraries,
we also created a proof-of-concept library of 18 different
circuits. We co-transfected all of them at the same time to-
gether with the BxB1 recombinase expression vector in our
landing pad chassis cell line. Since there were no significant
differences between the occurrences of the 18 different phe-
notypes within the polyclonal selected cell population, we
expect that our framework could readily support the screen-
ing of a significantly higher number of circuits. In compar-
ison to transient transfections and random stable transfec-
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Figure 5. One pot integration of payload library. (A) Architecture of the payload library. The first fluorescent reporter (EYFP, mKate2 or Cerulean) is
fused to a nuclear localization tag. The second fluorescent reporter, different from the first one, is tagged either with an utrophin localization signal, a
mitochondrial localization signal or with no localization signal. All possible combinations result in a library of 18 different payloads. (B) Fluorescent
microscopy images of microcolonies 7 days after selection with puromycin (10 days after transfection of equimolar amount of the 18 plasmids and BxB1
expression plasmid in HEK293FTLP chassis cell line) and no cell passaging. All 18 phenotypes were observed and are shown. (C and D) Fluorescence
microscopy images of polyclonal population 14 days after transfection, with 10x (C) and 40x (D)magnification, after cell passaging. (E)Average number of
each cell phenotype appearance in 500 classified cells. Error bars represent the standard deviation from these classifications performed over three different
fields of views from three independently repeated experiments (total of 4500 classified cells).
tions which lead to heterogeneous and often inconsistent
gene expression, our approach enables the evaluation of li-
braries of genetic constructs in the same genomic context,
and therefore the side-by-side comparison of circuit behav-
ior over an extended period of time. At the part level, our
platform could be useful to test the activity of libraries of
synthetic DNA promoters or enhancers in order to better
understand the architecture of gene regulatory regions since
gene activity is modulated by a complex interplay between
these cis- and trans- acting DNA elements. At the circuit
level, creating and stably integrating libraries of circuits in
which the position and orientation of specific parts or tran-
scription units are shuffled could be used to evaluate pro-
moter interference. Preliminary results indeed indicate that
part positioning within a circuit can influence transgene ex-
pression levels and overall dynamics. Libraries of therapeu-
tically relevant circuits, such as prosthetic networks (14) or
T cell proliferation controllers (42), could be rapidly evalu-
ated in parallel to tune their parameters and optimize their
sensitivity. In summary, our framework could accelerate the
development of a well-characterized and standardized parts
libraries for genetic engineering and also help create rules
for the design of synthetic networks with better prediction
accuracy, useful for a broad range of applications from sys-
tems and synthetic biology to biotechnology and medicine.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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